查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1476375

到 2030 年合法大麻市场预测：按产品类型、化合物、交付模式、种类、分销管道、应用、最终用户和地区进行的全球分析

Legal Marijuana Market Forecasts to 2030 - Global Analysis By Product Type (Tinctures, Flower Buds, Oils, Topicals and Other Product Types), Compound, Mode of Delivery, Species, Distribution Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球合法大麻市场规模将达到 210 亿美元，预计到 2030 年将达到 1,162 亿美元，预测期内复合年增长率为 27.7%。

大麻是干燥的大麻植物部分的干燥混合物，颜色为绿色、棕色或灰色。这种植物被广泛用作治疗各种疾病的娱乐药物。在许多国家，出于娱乐和医疗目的种植、拥有和分销大麻是合法的。大麻自古以来就被用于药用，但它并不是治疗的首选药物。由于对其潜在医疗用途的研究，大麻目前用于许多适应症。

2023 年《Jama Network Open》上发表的一项研究发现，超过一半的成年人（1,661 人中有 948 人）使用大麻来治疗慢性疼痛。

扩大医疗环境的接受度

由于人们越来越认识到大麻的治疗潜力，大麻市场的医疗接受度正在显着上升。正在进行的研究正在揭示大麻化合物的药用特性，越来越多的医疗专业人员正在接受其用于治疗各种疾病，包括慢性疼痛、癫痫和焦虑。这种日益增长的接受度正在推动思维方式的改变，导致合法化的扩大和针对患者需求的新医用大麻产品的发展。

严格的法规和法律障碍

医用大麻市场面临严格的监管和众多的法律障碍，为企业和消费者带来了重大挑战。这些障碍包括许可证要求、税务复杂性、联邦银行限制、遵守各种州法规以及严格的产品测试标准。此外，该行业还面临供应链物流、行销法规和持续的立法变革等问题，为相关人员创造了一个复杂的环境。

创新和产品开发

公司正在投资研究，以创造新的菌株、食品和饮料等注入产品，以及电子烟和外用药等先进的输送方法。这种动态情况正在推动种植者、製造商和科技公司之间的合作，以创造更安全、更有效、剂量更精确的大麻产品，以满足不断变化的市场需求。

公共卫生问题

大麻市场引起了公众对滥用可能性的担忧，特别是在弱势群体中。问题包括过量摄取导致驾驶和认知功能受损、成瘾风险以及对产品品质和效力的监管不足。此外，人们也担心二手烟暴露和频繁吸食大麻对健康的长期影响。因此，这些都是阻碍市场成长的因素。

COVID-19 的影响：

COVID-19 大流行对合法大麻市场产生了多种影响。一方面，它刺激了寻求缓解压力和替代医学的人们的需求增加。结果，我们在一些地区实现了创纪录的销售额。另一方面，供应链中断、药局暂时关闭和经济不确定性成为问题。也实施了监管改革，包括允许路边取货和送货。总体而言，市场表现出韧性，但由于疫情的不可预测性而面临营运障碍。

预计预测期内花蕾田规模最大

预计花蕾田在预测期内将是最大的。花蕾也称为花蕾，是植物中最有效的部分，含有高浓度的大麻素。品质是决定消费者偏好的重要因素，香气、风味和外观等特征会影响购买决策。种植者致力于优化生长条件，以生产具有不同形状的緻密、树脂质芽，以满足大麻鑑赏家的不同偏好。

预计製药业在预测期内复合年增长率最高

预计製药业在预测期内复合年增长率最高。公司正在探索大麻素对各种医疗状况的治疗潜力。从疼痛管理到神经系统疾病，药物正在探索各种应用，以满足监管标准并创造满足患者需求的创新治疗方法。药物和合法大麻的这种交叉是医疗保健创新的一个有前途的前沿。

比最大的地区

在态度转变和监管变化的推动下，预计北美在预测期内将占据最大的市场占有率。这种增长催生了各种各样的产品，从传统花卉到食用品、浓缩物和外用药。合法化使消费者可以获得各种各样的大麻产品。该市场吸引了大量投资、创造就业机会并产生税收。

复合年增长率最高的地区：

预计亚太地区在预测期内复合年增长率最高。在该地区大多数国家，娱乐性使用大麻仍然普遍违法。然而，有一些关于出于休閒目的将其合法化或合法化的可能性的运动和讨论。希望利用新兴合法大麻市场的投资者和公司对该地区的兴趣日益浓厚。这不仅包括种植和分销，还包括大麻药物的研究和开发。

免费客製化服务

订阅此报告的客户将收到以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球合法大麻市场：依产品类型

  • 酊剂
  • 花蕾
  • 油
  • 外用药
  • 其他产品类型

第六章 全球合法大麻市场：依化合物分类

  • 大麻二酚 (CBD) 占主导地位
  • 稳定的 THC/CBD
  • 四氢大麻酚 (THC) 占主导地位

第七章 全球合法大麻市场：以运输方式

  • 食用
  • 胶囊
  • 集中

第八章全球合法大麻市场：依种类

  • 混合
  • Sativa
  • 籼稻

第九章 全球合法大麻市场：依通路分类

  • 药局
  • 网路零售
  • 药局
  • 其他分销管道

第十章 全球合法大麻市场：依应用分类

  • 医疗保健
    • 关节炎
    • 青光眼
    • 糖尿病
  • 成人
  • 其他用途

第十一章 全球合法大麻市场：依最终使用者分类

  • 饮食
  • 烟草
  • 製药
  • 个人护理
  • 其他最终用户

第十二章 全球合法大麻市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第十三章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十四章 公司概况

  • Green Roads
  • VIVO Cannabis Inc.
  • Organigram Holding, Inc.
  • Dr. Hemp Me.
  • Gaia Herbs Farm
  • Royal CBD
  • Canopy Growth Corporation
  • Hemp Production Services
  • CV Sciences, Inc.
  • Aphria, Inc.
  • Isodiol International Inc
  • The Cronos Group
  • Medical Marijuana, Inc.
  • Aurora Cannabis
  • GW Pharmaceuticals, plc.
Product Code: SMRC25921

According to Stratistics MRC, the Global Legal Marijuana Market is accounted for $21.0 billion in 2023 and is expected to reach $116.2 billion by 2030 growing at a CAGR of 27.7% during the forecast period. Marijuana is the dry mixture of dried marijuana plant parts that is green, brown, or grey in color. This plant is widely used as a recreational drug to treat various ailments. In many nations, it is legal to grow, possess, and distribute marijuana for both recreational and medical purposes. Although it has long been used medicinally, cannabis is not the first choice for treatment. Cannabis is now used for a number of indications as a result of research into its potential medical uses.

According to a study published in Jama Network Open in 2023, more than half of adults (948 out of 1661) used cannabis to manage their chronic pain.

Market Dynamics:

Driver:

Rising medical acceptance

The market is experiencing a notable rise in medical acceptance due to growing recognition of its therapeutic potential. With ongoing research revealing the medicinal benefits of cannabis compounds, more medical professionals are embracing its use for various conditions like chronic pain, epilepsy, and anxiety. This increasing acceptance is fostering a shift in attitudes, leading to expanded legalization and the development of new medical cannabis products tailored to meet patients' needs.

Restraint:

Strict regulations and legal hurdles

The market faces strict regulations and numerous legal hurdles, posing significant challenges to businesses and consumers alike. These barriers include licensing requirements, taxation complexities, banking limitations due to federal laws, compliance with varying state regulations, and stringent product testing standards. Additionally, the industry contends with issues such as supply chain logistics, marketing restrictions, and ongoing changes in legislation, making it a complex landscape for stakeholders to navigate and thrive within.

Opportunity:

Innovation and product development

Companies are investing in research to create novel strains, infused products like edibles and beverages, and advanced delivery methods such as vaping and topicals. This dynamic landscape encourages collaborations between growers, manufacturers, and tech companies, leading to the creation of safer, more potent, and precisely dosed cannabis products that cater to evolving market demands.

Threat:

Public health concerns

The market raises public health concerns regarding potential misuse, especially among vulnerable populations. Issues include overconsumption leading to impaired driving or cognitive function, addiction risks, and inadequate regulation of product quality and potency. Additionally, there are concerns about second-hand smoke exposure and the long-term health effects of frequent marijuana use. Therefore, these are the factors hampering the growth of the market.

Covid-19 Impact:

The COVID-19 pandemic has had a mixed impact on the legal marijuana market. On one hand, it spurred increased demand as people sought stress relief and alternative medical treatments. This led to record sales in some regions. Conversely, supply chain disruptions, temporary dispensary closures, and economic uncertainty posed challenges. Regulatory changes, such as allowing curbside pickup and delivery, were also implemented. Overall, the market demonstrated resilience but faced operational hurdles due to the pandemic's unpredictability.

The flower buds segment is expected to be the largest during the forecast period

The flower buds segment is expected to be the largest during the forecast period. These buds, also known as nugs, are the most potent part of the plant, containing high concentrations of cannabinoids. Their quality is a key factor in consumer preferences, with characteristics like aroma, flavor, and appearance influencing purchasing decisions. Cultivators focus on optimizing growth conditions to produce dense, resinous buds with diverse profiles to cater to the varied tastes of cannabis enthusiasts.

The pharmaceutical segment is expected to have the highest CAGR during the forecast period

The pharmaceutical segment is expected to have the highest CAGR during the forecast period. Companies are exploring the therapeutic potential of cannabinoids for various medical conditions. From pain management to neurological disorders, pharmaceuticals are exploring various applications, aiming to create innovative treatments that meet regulatory standards and address patients' needs. This intersection of pharmaceuticals and legal marijuana represents a promising frontier in healthcare innovation.

Region with largest share:

North America is projected to hold the largest market share during the forecast period propelled by shifting attitudes and regulatory changes. This growth has led to a diverse range of products, from traditional flower to edibles, concentrates, and topical. Legalization has led to a wide range of cannabis products being available to consumers. The market has attracted substantial investment, creating jobs and generating tax revenue.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period. The recreational use of marijuana is generally still illegal in most countries in the region. However, there are movements and discussions in some places about potential decriminalization or legalization for recreational purposes. There is a growing interest from investors and businesses in the region to capitalize on the emerging legal marijuana market. This includes not only cultivation and distribution but also research and development of cannabis-based pharmaceuticals.

Key players in the market

Some of the key players in Legal Marijuana market include Green Roads, VIVO Cannabis Inc., Organigram Holding, Inc., Dr. Hemp Me., Gaia Herbs Farm, Royal CBD, Canopy Growth Corporation, Hemp Production Services, CV Sciences, Inc. , Aphria, Inc., Isodiol International Inc, The Cronos Group, Medical Marijuana, Inc. , Aurora Cannabis and GW Pharmaceuticals, plc.

Key Developments:

In January 2024, Village Farms International, Inc., announced the launch of two cannabis brands in the UK, such as Pure Sunfarms and The Original Fraser Valley Weed Co. (Fraser Valley). 4C LABS, a UK-based medical cannabis company, will distribute these brands.

In March 2023, Canopy Growth introduced six new beverage flavors. Under the Deep Space brand, the company announced Canada's first cannabis-infused beverage with naturally occurring caffeine.

Product Types Covered:

  • Tinctures
  • Flower Buds
  • Oils
  • Topicals
  • Other Product Types

Compounds Covered:

  • Cannabidiol (CBD)-Dominant
  • Balanced THC & CBD
  • Tetrahydrocannabinol (THC)-Dominant

Mode of Deliveries Covered:

  • Edibles
  • Capsules
  • Concentrates

Species Covered:

  • Hybrid
  • Sativa
  • Indica

Distribution Channels Covered:

  • Dispensaries
  • Online Retail
  • Pharmacies
  • Other Distribution Channels

Applications Covered:

  • Medical
  • Adult Use
  • Other Applications

End Users Covered:

  • Food and Beverages
  • Tobacco
  • Pharmaceutical
  • Personal Care
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Legal Marijuana Market, By Product Type

  • 5.1 Introduction
  • 5.2 Tinctures
  • 5.3 Flower Buds
  • 5.4 Oils
  • 5.5 Topicals
  • 5.6 Other Product Types

6 Global Legal Marijuana Market, By Compound

  • 6.1 Introduction
  • 6.2 Cannabidiol (CBD)-Dominant
  • 6.3 Balanced THC & CBD
  • 6.4 Tetrahydrocannabinol (THC)-Dominant

7 Global Legal Marijuana Market, By Mode of Delivery

  • 7.1 Introduction
  • 7.2 Edibles
  • 7.3 Capsules
  • 7.4 Concentrates

8 Global Legal Marijuana Market, By Species

  • 8.1 Introduction
  • 8.2 Hybrid
  • 8.3 Sativa
  • 8.4 Indica

9 Global Legal Marijuana Market, By Distribution Channel

  • 9.1 Introduction
  • 9.2 Dispensaries
  • 9.3 Online Retail
  • 9.4 Pharmacies
  • 9.5 Other Distribution Channels

10 Global Legal Marijuana Market, By Application

  • 10.1 Introduction
  • 10.2 Medical
    • 10.2.1 Arthritis
    • 10.2.2 Glaucoma
    • 10.2.3 Diabetes
  • 10.3 Adult Use
  • 10.4 Other Applications

11 Global Legal Marijuana Market, By End User

  • 11.1 Introduction
  • 11.2 Food and Beverages
  • 11.3 Tobacco
  • 11.4 Pharmaceutical
  • 11.5 Personal Care
  • 11.6 Other End Users

12 Global Legal Marijuana Market, By Geography

  • 12.1 Introduction
  • 12.2 North America
    • 12.2.1 US
    • 12.2.2 Canada
    • 12.2.3 Mexico
  • 12.3 Europe
    • 12.3.1 Germany
    • 12.3.2 UK
    • 12.3.3 Italy
    • 12.3.4 France
    • 12.3.5 Spain
    • 12.3.6 Rest of Europe
  • 12.4 Asia Pacific
    • 12.4.1 Japan
    • 12.4.2 China
    • 12.4.3 India
    • 12.4.4 Australia
    • 12.4.5 New Zealand
    • 12.4.6 South Korea
    • 12.4.7 Rest of Asia Pacific
  • 12.5 South America
    • 12.5.1 Argentina
    • 12.5.2 Brazil
    • 12.5.3 Chile
    • 12.5.4 Rest of South America
  • 12.6 Middle East & Africa
    • 12.6.1 Saudi Arabia
    • 12.6.2 UAE
    • 12.6.3 Qatar
    • 12.6.4 South Africa
    • 12.6.5 Rest of Middle East & Africa

13 Key Developments

  • 13.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 13.2 Acquisitions & Mergers
  • 13.3 New Product Launch
  • 13.4 Expansions
  • 13.5 Other Key Strategies

14 Company Profiling

  • 14.1 Green Roads
  • 14.2 VIVO Cannabis Inc.
  • 14.3 Organigram Holding, Inc.
  • 14.4 Dr. Hemp Me.
  • 14.5 Gaia Herbs Farm
  • 14.6 Royal CBD
  • 14.7 Canopy Growth Corporation
  • 14.8 Hemp Production Services
  • 14.9 CV Sciences, Inc.
  • 14.10 Aphria, Inc.
  • 14.11 Isodiol International Inc
  • 14.12 The Cronos Group
  • 14.13 Medical Marijuana, Inc.
  • 14.14 Aurora Cannabis
  • 14.15 GW Pharmaceuticals, plc.

List of Tables

  • Table 1 Global Legal Marijuana Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Legal Marijuana Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Legal Marijuana Market Outlook, By Tinctures (2021-2030) ($MN)
  • Table 4 Global Legal Marijuana Market Outlook, By Flower Buds (2021-2030) ($MN)
  • Table 5 Global Legal Marijuana Market Outlook, By Oils (2021-2030) ($MN)
  • Table 6 Global Legal Marijuana Market Outlook, By Topicals (2021-2030) ($MN)
  • Table 7 Global Legal Marijuana Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 8 Global Legal Marijuana Market Outlook, By Compound (2021-2030) ($MN)
  • Table 9 Global Legal Marijuana Market Outlook, By Cannabidiol (CBD)-Dominant (2021-2030) ($MN)
  • Table 10 Global Legal Marijuana Market Outlook, By Balanced THC & CBD (2021-2030) ($MN)
  • Table 11 Global Legal Marijuana Market Outlook, By Tetrahydrocannabinol (THC)-Dominant (2021-2030) ($MN)
  • Table 12 Global Legal Marijuana Market Outlook, By Mode of Delivery (2021-2030) ($MN)
  • Table 13 Global Legal Marijuana Market Outlook, By Edibles (2021-2030) ($MN)
  • Table 14 Global Legal Marijuana Market Outlook, By Capsules (2021-2030) ($MN)
  • Table 15 Global Legal Marijuana Market Outlook, By Concentrates (2021-2030) ($MN)
  • Table 16 Global Legal Marijuana Market Outlook, By Species (2021-2030) ($MN)
  • Table 17 Global Legal Marijuana Market Outlook, By Hybrid (2021-2030) ($MN)
  • Table 18 Global Legal Marijuana Market Outlook, By Sativa (2021-2030) ($MN)
  • Table 19 Global Legal Marijuana Market Outlook, By Indica (2021-2030) ($MN)
  • Table 20 Global Legal Marijuana Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 21 Global Legal Marijuana Market Outlook, By Dispensaries (2021-2030) ($MN)
  • Table 22 Global Legal Marijuana Market Outlook, By Online Retail (2021-2030) ($MN)
  • Table 23 Global Legal Marijuana Market Outlook, By Pharmacies (2021-2030) ($MN)
  • Table 24 Global Legal Marijuana Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
  • Table 25 Global Legal Marijuana Market Outlook, By Application (2021-2030) ($MN)
  • Table 26 Global Legal Marijuana Market Outlook, By Medical (2021-2030) ($MN)
  • Table 27 Global Legal Marijuana Market Outlook, By Arthritis (2021-2030) ($MN)
  • Table 28 Global Legal Marijuana Market Outlook, By Glaucoma (2021-2030) ($MN)
  • Table 29 Global Legal Marijuana Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 30 Global Legal Marijuana Market Outlook, By Adult Use (2021-2030) ($MN)
  • Table 31 Global Legal Marijuana Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 32 Global Legal Marijuana Market Outlook, By End User (2021-2030) ($MN)
  • Table 33 Global Legal Marijuana Market Outlook, By Food and Beverages (2021-2030) ($MN)
  • Table 34 Global Legal Marijuana Market Outlook, By Tobacco (2021-2030) ($MN)
  • Table 35 Global Legal Marijuana Market Outlook, By Pharmaceutical (2021-2030) ($MN)
  • Table 36 Global Legal Marijuana Market Outlook, By Personal Care (2021-2030) ($MN)
  • Table 37 Global Legal Marijuana Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.